These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16548923)

  • 1. Do antagonists have a role in the treatment of opioid dependence?
    Jaffe JH
    Addiction; 2006 Apr; 101(4):468-9. PubMed ID: 16548923
    [No Abstract]   [Full Text] [Related]  

  • 2. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
    Poser W; Ehrenreich H
    Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453
    [No Abstract]   [Full Text] [Related]  

  • 3. Opioid antagonists: do they have a role in treatment programs?
    O'Brien CP; Greenstein RA; Evans B; Woody GE; Arndt R
    NIDA Res Monogr; 1983 Apr; 43():71-8. PubMed ID: 6410281
    [No Abstract]   [Full Text] [Related]  

  • 4. Can psychotherapy rescue naltrexone treatment of opioid addiction?
    Rounsaville BJ
    NIDA Res Monogr; 1995; 150():37-52. PubMed ID: 8742771
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review.
    Johansson BA; Berglund M; Lindgren A
    Addiction; 2006 Apr; 101(4):491-503. PubMed ID: 16548929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone-mediated opiate detoxification: a matter of terminology!
    Johnson TS; Carr M
    Addict Biol; 2003 Sep; 8(3):267-9. PubMed ID: 13129827
    [No Abstract]   [Full Text] [Related]  

  • 7. General anaesthesia is patient-friendly in opioid antagonist detoxification treatment.
    De Jong CJ
    Addiction; 2005 Nov; 100(11):1742-4. PubMed ID: 16277635
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
    Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
    Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to Degenhardt et al.: 'depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy'.
    Brewer C
    Drug Alcohol Rev; 2008 Jul; 27(4):447-8; author reply 448-9. PubMed ID: 18584398
    [No Abstract]   [Full Text] [Related]  

  • 11. De Jong, Krabbe, Laheij & Van Cauter refuted: evidence-based non-effectiveness can hardly be patient-friendly.
    de Jong CJ; Laheij RJ; Krabbe PF; van Cauter Victory RM
    Addiction; 2005 Dec; 100(12):1884-5. PubMed ID: 16367990
    [No Abstract]   [Full Text] [Related]  

  • 12. Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy.
    Degenhardt L; Gibson A; Mattick RP; Hall W
    Drug Alcohol Rev; 2008 Jan; 27(1):1-3. PubMed ID: 18034375
    [No Abstract]   [Full Text] [Related]  

  • 13. Unintentional rapid opioid detoxification: case report.
    Singh SM; Sharma B
    Psychiatr Danub; 2009 Mar; 21(1):65-7. PubMed ID: 19270623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone in the treatment of opioid dependence.
    George S; Ekhtiari H
    Br J Hosp Med (Lond); 2010 Oct; 71(10):568-70. PubMed ID: 21085073
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid opioid detoxification.
    Gooberman LL
    JAMA; 1998 Jun; 279(23):1871; author reply 1872. PubMed ID: 9634250
    [No Abstract]   [Full Text] [Related]  

  • 16. Does naltrexone affect craving in abstinent opioid-dependent patients?
    Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP
    Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reentry using naltrexone: one anesthesia department's experience.
    Hudson S
    AANA J; 1998 Aug; 66(4):360-4. PubMed ID: 9830862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders.
    McCann DJ
    Clin Pharmacol Ther; 2008 Apr; 83(4):627-30. PubMed ID: 18212797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine.
    Reece AS
    J Subst Abuse Treat; 2009 Oct; 37(3):256-65. PubMed ID: 19394789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra-rapid opioid detoxification: current status and controversies.
    Singh J; Basu D
    J Postgrad Med; 2004; 50(3):227-32. PubMed ID: 15377814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.